← Research.Patient.info
Browse research by treatment
1,000 treatments and interventions are being studied right now — from new medicines to therapies, devices and lifestyle programmes.
- Placebo6581159
- Pembrolizumab104207
- Carboplatin65135
- Cisplatin52112
- Paclitaxel40103
- Dexamethasone4485
- Cyclophosphamide3983
- Durvalumab2980
- gemcitabine4176
- Nivolumab3174
- Docetaxel3269
- Bevacizumab4069
- Atezolizumab2266
- Rituximab2666
- Pemetrexed2763
- Lenalidomide1857
- No intervention4957
- Capecitabine2450
- Oxaliplatin2448
- Doxorubicin2547
- Prednisone2044
- Standard of Care2643
- blood sample3038
- Daratumumab1938
- MRI3138
- nab-paclitaxel1738
- Questionnaires3237
- Venetoclax1937
- Fludarabine1736
- Biospecimen Collection1936
- Magnetic Resonance Imaging2034
- Pomalidomide1634
- Fulvestrant1433
- Bortezomib1132
- Olaparib1132
- Radiotherapy1531
- Vincristine1430
- Obinutuzumab1230
- Enzalutamide1330
- Cetuximab1930
- Etoposide1430
- Irinotecan1629
- Tocilizumab1629
- Letrozole1228
- Questionnaire2628
- Abemaciclib1228
- Radiation Therapy1028
- Temozolomide1527
- Leucovorin1627
- blood sampling2426
- Trastuzumab1226
- Computed Tomography1125
- Trastuzumab deruxtecan1525
- Exercise1724
- Palbociclib724
- Usual care1723
- ribociclib1323
- Ruxolitinib922
- Control1422
- Everolimus1022
- Cabozantinib821
- Epcoritamab421
- Fluorouracil1021
- Quality-of-Life Assessment721
- Questionnaire Administration921
- Semaglutide821
- Sacituzumab Tirumotecan1521
- Acalabrutinib820
- Dostarlimab720
- Rilvegostomig1620
- Azacitidine820
- Cytarabine919
- Lenvatinib519
- Data Collection1619
- Carfilzomib819
- Ipilimumab919
- Cemiplimab718
- Teclistamab818
- Inavolisib1018
- Exemestane818
- Amivantamab818
- Risankizumab918
- Bendamustine918
- Laboratory Biomarker Analysis218
- Osimertinib417
- Tirzepatide1017
- Baricitinib817
- Pumitamig1717
- Dupilumab616
- Prednisolone1016
- Tremelimumab516
- Anastrozole616
- Observation1216
- Upadacitinib716
- Chemotherapy916
- 5-fluorouracil1216
- Guselkumab516
- Zanubrutinib616
- Topotecan916
- Methotrexate715
- Avelumab315
- Midazolam815
- Niraparib515
- trametinib615
- Belzutifan615
- Abiraterone acetate414
- Methylprednisolone614
- Sunitinib714
- The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.13
- The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.13
- Blood samples1113
- Pirtobrutinib713
- Rescue Medication1313
- Ibrutinib513
- Glofitamab613
- Talquetamab613
- Vinorelbine613
- Bimekizumab412
- Elranatamab912
- Tamoxifen512
- Apalutamide312
- Control Group1012
- KEYTRUDA 25 mg/mL concentrate for solution for infusion12
- Mirikizumab812
- Ocrelizumab212
- Positron Emission Tomography812
- Abiraterone711
- Metformin311
- biopsy911
- Blood test1111
- Capivasertib311
- Matching Placebo711
- Deucravacitinib411
- Biopsy Procedure511
- Entrectinib310
- Eribulin310
- Iberdomide510
- Pertuzumab410
- Giredestrant410
- Darolutamide610
- No Intervention: Observational Cohort1010
- Surgery610
- Orforglipron510
- Isatuximab610
- Tacrolimus510
- Placebo Administration410
- Ifosfamide710
- standard care710
- Enfortumab Vedotin410
- Volrustomig610
- empagliflozin810
- Dacarbazine410
- IMVT-1402810
- Dato-DXd510
- Sonrotoclax710
- Belantamab mafodotin410
- Ustekinumab310
- Nipocalimab69
- Anakinra69
- Sotorasib39
- Bone Scan79
- Observational79
- Polatuzumab vedotin39
- Adagrasib79
- Alectinib39
- Sample collection99
- Tezepelumab49
- Tislelizumab69
- Virtual Reality79
- FOLFOX89
- Radiation59
- Placebo Oral Tablet59
- Tucatinib39
- Filgotinib59
- Selinexor9
- Panitumumab89
- Afimkibart79
- KarXT99
- Adalimumab39
- Retatrutide29
- Alpelisib28
- Tarlatamab28
- Psilocybin58
- Iptacopan38
- Luspatercept48
- Mitapivat18
- not applicable, observational study88
- Saline68
- normal saline78
- Pulmonary vein isolation78
- Efgartigimod PH20 SC48
- ianalumab38
- Sacituzumab Govitecan58
- Rescue Medications58
- Odronextamab68
- Blinatumomab78
- Echocardiography Test68
- Multigated Acquisition Scan58
- SBRT48
- IMFINZI 50 mg/mL concentrate for solution for infusion.8
- Apixaban48
- Dasatinib38
- Cagrilintide28
- Ramucirumab38
- Hydrocortisone37
- Zanidatamab67
- Datopotamab Deruxtecan17
- Inclisiran57
- Atogepant37
- Sham (No Treatment)77
- The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. Full details will be added to the study record within 30 months after the trial has ended.7
- Tulisokibart27
- Busulfan57
- Cardiac MRI47
- deucrictibant67
- Echocardiogram77
- Lumbar puncture67
- MRI scan57
- PET-MRI67
- rilzabrutinib47
- Teriflunomide17
- Trifluridine-Tipiracil47
- ADT17
- Bariatric surgery67
- Biological collection77
- Blood sample collection77
- Cognitive assessment67
- Depemokimab57
- Diet77
- Secukinumab17
- Stereotactic Ablative Radiotherapy37
- Surovatamig77
- LHRH Agonist17
- Benralizumab37
- folinic acid47
- Linvoseltamab77
- Amlitelimab7
- Platinum-based chemotherapy37
- Corticosteroids37
- Divarasib47
- Questionnaire and Physical Exam77
- Temozolomide (TMZ)57
- NNC0487-011177
- Lazertinib27
- Encorafenib37
- Zimberelimab17
- Tiragolumab27
- Sonelokimab27
- Rivaroxaban47
- Amoxicillin26
- Camizestrant46
- Dexmedetomidine56
- Inulin66
- Ipatasertib26
- Placebo IV46
- Sacituzumab Govitecan-hziy26
- Belimumab46
- JNJ-772421136
- FOLFIRI66
- Elecoglipron66
- Breath test56
- PREHABILITATION56
- Lutikizumab16
- Vedolizumab56
- Venepuncture46
- AZD012066
- Ezabenlimab16
- Gemcitabine/Cisplatin16
- Non Interventional46
- Non-Interventional Study56
- Routine care66
- Stereotactic Body Radiotherapy36
- Transcranial Direct Current Stimulation56
- vincristine sulfate6
- Whey protein66
- 5-Fluorouracil (5-FU)66
- binimetinib46
- Brenipatide66
- Cetrelimab16
- Exercise Training66
- Lebrikizumab16
- levoleucovorin36
- Neuropsychological tests56
- Pembrolizumab (KEYTRUDA®)46
- Prednisone/Prednisolone56
- Sham procedure26
- Sotatercept36
- Standard treatment56
- APG77736
- Pemetrexed/Carboplatin16
- riliprubart46
- sparsentan46
- Trastuzumab Emtansine16
- vinblastine46
- Telisotuzumab Adizutecan46
- Standard of Care (SOC)46
- Sham46
- Calderasib66
- Domvanalimab16
- Elotuzumab26
- Patritumab Deruxtecan46
- XBD17366
- AZD139036
- Frexalimab36
- Mosunetuzumab46
- Zanzalintinib56
- Risdiplam56
- 5-FU16
- Saruparib36
- Azacitidine (AZA)56
- Remibrutinib26
- Aspirin46
- Bone Marrow Aspiration26
- Melphalan46
- Intensity-Modulated Radiation Therapy26
- Crizotinib26
- Ceralasertib26
- Zilovertamab vedotin56
- Elacestrant45
- Lecanemab5
- Cefazolin35
- Golcadomide25
- Mitomycin C25
- Radiofrequency ablation45
- Route of administration: oral use5
- Vehicle Cream45
- Brachytherapy25
- Regorafenib25
- AZD98335
- Active Surveillance35
- Exercise Intervention45
- Futibatinib35
- Dapagliflozin35
- Ravulizumab25
- Colonoscopy55
- Ketamine Hydrochloride45
- Observational study55
- Anifrolumab45
- indocyanine green35
- Lunsekimig45
- Liver biopsy45
- radical prostatectomy15
- Saliva sample25
- Time-restricted eating55
- Urine sample35
- vicadrostat45
- 177Lu-PSMA-61725
- Aerobic exercise45
- Botulinum toxin type A15
- Dietary Intervention35
- Interview45
- Magnetic Resonance Imaging (MRI)55
- Maridebart cafraglutide35
- mycophenolate mofetil55
- Percutaneous coronary intervention45
- Photobiomodulation55
- Physiotherapy45
- placebo capsule25
- Quality of life questionnaires35
- Relatlimab35
- Rosuvastatin45
- Smartwatch45
- BCG35
- bleomycin15
- Brentuximab vedotin35
- Emicizumab35
- Ifinatamab deruxtecan45
- Pemetrexed/Cisplatin15
- barzolvolimab25
- daraxonrasib55
- Etentamig35
- Inebilizumab45
- Placebo control55
- Placebo tablet35
- Furmonertinib5
- Momelotinib55
- Intismeran autogene25
- Elritercept55
- Nivolumab + Relatlimab45
- Opevesostat55
- Zongertinib35
- Pegcetacoplan35
- Supportive care measures35
- Obexelimab15
- Selumetinib15
- Capmatinib35
- Cobimetinib15
- Patient Observation25
- Placebo (matched to NNC0487-0111)55
- Stereotactic Body Radiation Therapy15
- Ultrasound35
- Bone Marrow Biopsy15
- Oleclumab15
- Norepinephrine55
- Nerandomilast55
- Mavacamten25
- KarX-EC55
- Felzartamab35
- Ritlecitinib15
- Colchicine34
- Datopotamab Deruxtecan (Dato-DXd)44
- Prostate biopsy14
- Bleximenib34
- Transthoracic Echocardiogram34
- Vosoritide24
- Azithromycin34
- Claseprubart24
- Gemcitabine + carboplatin4
- Optimal Medical Therapy24
- T-DXd24
- Ranibizumab14
- Androgen Deprivation Therapy (ADT)24
- Survodutide24
- transthoracic echocardiography44
- CGT948644
- Escitalopram34
- AZD530524
- Sodium Chloride24
- Transcranial Direct Current Stimulation (tDCS)44
- Transcranial Magnetic Stimulation24
- [177Lu]Lu-DOTA-TATE14
- Aortic valve replacement34
- BGB-1141734
- ECG44
- Enoxaparin24
- Itepekimab (SAR440340)4
- mezigdomide34
- Blood tests44
- SYT-51044
- Povetacicept24
- Standard Care (in control arm)44
- Cabazitaxel34
- education34
- Electrocardiogram34
- Fianlimab4
- Mitapivat-matching placebo4
- Icotrokinra34
- Nilotinib14
- Ofatumumab24
- Povorcitinib14
- Sacituzumab Govitecan-hziy (SG)14
- Skin biopsy34
- Standard of care treatment34
- Tranexamic Acid44
- BHV-700024
- Lutathera24
- Mepolizumab4
- Placebo semaglutide14
- Placebo supplement34
- disitamab vedotin14
- Tebentafusp24
- Treatment as Usual (TAU)34
- Aflibercept14
- AZD090124
- Biofeedback training44
- Blood collection34
- blood draw34
- Catheter ablation24
- Conduction System Pacing44
- dabrafenib24
- Finerenone (Kerendia, BAY94-8862)34
- garadacimab4
- glucose24
- goserelin24
- Hydroxyurea34
- LEUCOVORIN CALCIUM4
- Ivosidenib44
- Lung ultrasound44
- No interventions.44
- Non-invasive ventilation34
- Pacritinib24
- Placebos44
- Protein supplement34
- psilocybin (25 mg)44
- Quality of Life44
- DOR/ISL4
- rapcabtagene autoleucel34
- RCT21004
- LY353703144
- stereotactic body radiotherapy (SBRT)34
- Efgartigimod IV34
- CTx00124
- Zasocitinib44
- zolbetuximab24
- Anvumetostat4
- Belrestotug4
- Epoetin Alfa24
- Givinostat34
- Itraconazole34
- Remdesivir44
- Revumenib34
- tafasitamab4
- ALXN222014
- golexanolone4
- INZ-7014
- Bulevirtide14
- Pegaspargase14
- Nemolizumab14
- Idelalisib24
- Nirogacestat14
- Imlunestrant24
- Visugromab (CTL-002)34
- Budigalimab24
- Nemtabrutinib34
- Paltusotine14
- Pembrolizumab (+) Berahyaluronidase alfa24
- Pembrolizumab/Quavonlimab4
- Placebo for Atogepant14
- RO72042394
- Rucaparib14
- Saline Nasal Spray44
- Satralizumab24
- TAR-2004
- Vemurafenib14
- Venetoclax (VEN)34
- [177Lu]Lu-NeoB24
- [68Ga]Ga-NeoB24
- Sorafenib4
- Selpercatinib4
- MEDI47364
- Placebo Comparator34
- Plozasiran Injection14
- XEN110134
- AAA61734
- Belumosudil34
- BMS-98650444
- Chemotherapy drug44
- Cilta-cel4
- Daunorubicin34
- Dactinomycin24
- Efanesoctocog alfa34
- Repetitive Transcranial Magnetic Stimulation (rTMS)44
- RPT90444
- OPDIVO 10 mg/mL concentrate for solution for infusion.4
- Monalizumab14
- Lurbinectedin14
- Tecentriq 1 200 mg concentrate for solution for infusion4
- Imatinib34
- Forxiga 10 mg film-coated tablets4
- Degarelix14
- Cemdisiran24
- ASTX72724
- Apremilast34
- YERVOY 5 mg/ml concentrate for solution for infusion, OPDIVO 10 mg/mL concentrate for solution for infusion.4
- Tepotinib14
- Tazemetostat14
- Sirolimus34
- Rapamune 1 mg/mL oral solution4
- Pozelimab24
- Liposomal doxorubicin23
- Radiprodil13
- Waitlist33
- Acalabrutinib (ACP-196)3
- clindamycin23
- Doxycycline23
- Histology33
- intrathecal chemotherapy33
- Isatuximab SAR6509843
- AloCelyvir3
- ALXN18503
- Survey23
- Axatilimab13
- Yoga23
- Active Control23
- Fenebrutinib3
- Litifilimab13
- cochlear implantation23
- Fingolimod3
- MORPHINE23
- Axicabtagene Ciloleucel13
- Ropivacaine13
- Ruxolitinib Cream23
- Standard medical treatment33
- Baxdrostat/dapagliflozin23
- Best Available Therapy (BAT)3
- clinical examination33
- Phesgo23
- Electroencephalogram (EEG)33
- Bictegravir3
- Epidyolex 100 mg/ml oral solution3
- Bimatoprost SR3
- Biomarker analysis of blood samples33
- Microcrystalline Cellulose33
- MRI contrast-enhancing agents13
- BMS-98627813
- Bosutinib13
- Control (Standard treatment)23
- Relugolix3
- Repetitive Transcranial Magnetic Stimulation33
- savolitinib3
- Total knee arthroplasty23
- GTX-10223
- Cardiac Magnetic Resonance Imaging33
- Bepirovirsen3
- Caffeine33
- ENTR-601-4423
- ENTR-601-4523
- Intervention23
- Ipilimumab/ Nivolumab3
- JNJ-7827834323
Showing the top 600 of 1,000 matches — refine your search to narrow down.